(Q34252972)

English

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

progesterone-receptor positive breast cancer

0 references

1 reference

based on heuristic

inferred from title

author name string

Ran Gu

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Weijuan Jia

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yunjie Zeng

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nanyan Rao

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yue Hu

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Shunrong Li

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jiannan Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Liang Jin

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Lijuan Chen

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Meijun Long

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Kai Chen

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Lili Chen

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Qiaozhen Xiao

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mei Wu

14

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Erwei Song

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Fengxi Su

16

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

161

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Toremifene: an evaluation of its safety profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Meta-analysis of vascular and neoplastic events associated with tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Effects of tamoxifen on the human female genital tract: review of the literature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Evolving uses of hormonal agents for breast cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Toxicity of antiestrogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Cirrhosis with non alcoholic steatohepatitis: role of tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Occurrence of stroke with tamoxifen in NSABP B-24

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Tamoxifen-induced transient multifocal hepatic fatty infiltration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

The association between tamoxifen and the development of hepatocellular carcinoma: case report and literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Cirrhosis with steatohepatitis after adjuvant tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Eastern European Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Toremifene in postmenopausal breast cancer. Efficacy, safety and cost

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Safety assessment of tamoxifen and toremifene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Tamoxifen-associated eye disease. A review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3503787

6 July 2018

Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-161

21 January 2018

Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-161

21 January 2018

Uterine changes during tamoxifen, toremifene, and other therapy for breast cancer: evaluation with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-161

21 January 2018

Side Effects of Adjuvant Endocrine Treatment in Premenopausal Breast Cancer Patients: A Prospective Randomized Study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-161

21 January 2018

Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-161

21 January 2018

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-161

21 January 2018

Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-161

21 January 2018

A double-blind randomized controlled trial of toremifen therapy for mastalgia

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-161

21 January 2018

Bone mineral density and lipid changes during 5 years of follow-up in a study of prevention of breast cancer with toremifene in healthy, high-risk pre- and post-menopausal women

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-161

21 January 2018

Safety and Efficacy Results of a Randomized Trial Comparing Adjuvant Toremifene and Tamoxifen in Postmenopausal Patients With Node-Positive Breast Cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-161

21 January 2018

Tamoxifen and risk of large bowel cancer in women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22548922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22548922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/22548922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinopathy associated with low-dose tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/22548922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conformational studies and electronic structures of tamoxifen and toremifene and their allylic carbocations proposed as reactive intermediates leading to DNA adduct formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22548922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant endocrine therapy for premenopausal women with early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22548922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22548922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22548922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-12-161

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34252972&oldid=2196426149"